Conditions: Seasonal Allergic Rhinitis
Allocation: RANDOMIZED | Intervention model: PARALLEL
Enrollment: 1111
Healthy volunteers: no

Brief summary:
Study to evaluate the two different strengths and dose regimen of GSP 301 to be effective in treatment of seasonal allergic rhinitis.

Detailed description:

Arms:
arm 1: None arm 2: None arm 3: None arm 4: None arm 5: None arm 6: None arm 7: None

Interventions: intervention 1: GSP 301-1 NS (QD) intervention 2: GSP 301-2 NS (BID) intervention 3: GSP 301 Placebo NS intervention 4: Olopatadine HCl-1 NS (QD) intervention 5: Olopatadine HCl-2 NS (BID) intervention 6: Mometasone Furoate-1 NS (QD) intervention 7: Mometasone Furoate-2 NS (BID)
Intervention descriptions: intervention 1: GSP 301-1 NS (665 μg olopatadine hydrochloride/50 μg mometasone furoate) administered as 2 sprays/nostril intervention 2: GSP 301-2 NS (665 μg olopatadine hydrochloride/25 μg mometasone furoate) administered as 2 sprays/nostril intervention 3: GSP 301 placebo NS administered as 2 sprays/nostril intervention 4: Olopatadine HCl-1 NS (665 μg) administered as 2 sprays/nostril intervention 5: Olopatadine HCl-2 NS (665 μg) administered as 2 sprays/nostril intervention 6: Mometasone furoate -1 NS (50 μg) administered as 2 sprays/nostril intervention 7: Mometasone furoate-2 NS (25 μg) administered as 2 sprays/nostril

Protocol document: